HUNTER SYNDROME TREATMENT MARKET ANALYSIS

Hunter Syndrome Treatment Market, by Treatment Type (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others), by End Users (Hospitals, Clinics, Specialty Care Unit, and Others), and by Geography - Size, Share, Outlook and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1749
Formats :
Excel and PDF
Industry : Pharmaceutical

Hunter Syndrome Treatment MarketSize and Trends

Hunter Syndrome Treatment Market – Dynamics

As Hunter syndrome has no permanent cure, the treatment mainly focuses on management of indications, signs, and difficulties associated with the disease advancement. Increasing number of population suffering from hunter syndrome has boosted the market growth for Hunter syndrome treatments. For instance, in 2014, around 970 patients were enrolled in Hunter Outcome Survey (HOC) which increased to 1195 patients in 2017. Moreover, high burden of rare diseases, tax warier, fee reductions and grants, success for the drugs in pipeline with faster market access, financial incentives for orphan drug development to recover R&D costs, favorable regulations for orphan products development are some of the factors expected to fuel market growth over the forecast period. Rising attention of major biopharmaceutical companies on research and development of drugs for treatment of rare diseases is expected to boost demand for mucopolysaccharidosis treatment drugs. Moreover, the number of treatment options currently in pipeline is expected to boost the growth of market during the forecast period.